Glipizide class?

What “class” is glipizide in?

Glipizide is in the sulfonylurea drug class, a group of medicines used to treat type 2 diabetes. Sulfonylureas work by stimulating the pancreas to release more insulin.

How does glipizide compare with other diabetes drug classes?

Compared with other common type 2 diabetes classes:
- It is an insulin secretagogue (sulfonylurea), unlike metformin (which mainly reduces glucose production by the liver) or GLP-1 receptor agonists and DPP-4 inhibitors (which act on incretin pathways).
- Because it increases insulin release, it can raise the risk of hypoglycemia, a risk generally more associated with insulin and insulin-releasing medicines than with metformin or most newer incretin-based options.

Why does the sulfonylurea “class” matter for side effects?

Being a sulfonylurea means glipizide shares key class concerns:
- Hypoglycemia risk is a central consideration.
- Dose and meal timing can matter (skipping meals or taking extra without food increases risk).

Are there different types of sulfonylureas, and where does glipizide fit?

Within sulfonylureas, glipizide is one member of the class. Other sulfonylureas include drugs such as glyburide and glimepiride, which also act by increasing insulin secretion but differ in dosing and risk profiles.